Drugs / ZKY001 EYE DROPS
last change May 2022 re-read 3 minutes ago

ZKY001 EYE DROPS

Developed for
corneal disorder
Investigated by
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07132437 Dec 2021 → May 2022 corneal disorder Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ZKY001 EYE DROPS ClinicalTrials.gov intervention name — accepted as the source's own label NCT07132437 ↗
Route Topical “ZKY001 eye drops were dropped into the experimental eyes” NCT07132437 ↗